These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mechanisms of divergent effects of activated peroxisome proliferator-activated receptor-γ on mitochondrial citrate carrier expression in 3T3-L1 fibroblasts and mature adipocytes. Bonofiglio D; Santoro A; Martello E; Vizza D; Rovito D; Cappello AR; Barone I; Giordano C; Panza S; Catalano S; Iacobazzi V; Dolce V; Andò S Biochim Biophys Acta; 2013 Jun; 1831(6):1027-36. PubMed ID: 23370576 [TBL] [Abstract][Full Text] [Related]
3. Effects of high fat diet on GPR109A and GPR81 gene expression. Wanders D; Graff EC; Judd RL Biochem Biophys Res Commun; 2012 Aug; 425(2):278-83. PubMed ID: 22842580 [TBL] [Abstract][Full Text] [Related]
4. The DLK gene is a transcriptional target of PPARγ. Couture JP; Blouin R Biochem J; 2011 Aug; 438(1):93-101. PubMed ID: 21585338 [TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus (HIV)-1 viral protein R suppresses transcriptional activity of peroxisome proliferator-activated receptor {gamma} and inhibits adipocyte differentiation: implications for HIV-associated lipodystrophy. Shrivastav S; Kino T; Cunningham T; Ichijo T; Schubert U; Heinklein P; Chrousos GP; Kopp JB Mol Endocrinol; 2008 Feb; 22(2):234-47. PubMed ID: 17932108 [TBL] [Abstract][Full Text] [Related]
6. Trichostatin A modulates thiazolidinedione-mediated suppression of tumor necrosis factor α-induced lipolysis in 3T3-L1 adipocytes. Lu JC; Chang YT; Wang CT; Lin YC; Lin CK; Wu ZS PLoS One; 2013; 8(8):e71517. PubMed ID: 23951179 [TBL] [Abstract][Full Text] [Related]
7. Adipocyte expression of the glucose-dependent insulinotropic polypeptide receptor involves gene regulation by PPARγ and histone acetylation. Kim SJ; Nian C; McIntosh CH J Lipid Res; 2011 Apr; 52(4):759-70. PubMed ID: 21245029 [TBL] [Abstract][Full Text] [Related]
8. Palmitate induces fat accumulation by activating C/EBPβ-mediated G0S2 expression in HepG2 cells. Zhao NQ; Li XY; Wang L; Feng ZL; Li XF; Wen YF; Han JX World J Gastroenterol; 2017 Nov; 23(43):7705-7715. PubMed ID: 29209111 [TBL] [Abstract][Full Text] [Related]
9. The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the Wnt/beta-catenin pathways. Abdelkarim M; Caron S; Duhem C; Prawitt J; Dumont J; Lucas A; Bouchaert E; Briand O; Brozek J; Kuipers F; Fievet C; Cariou B; Staels B J Biol Chem; 2010 Nov; 285(47):36759-67. PubMed ID: 20851881 [TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone induction of Insig-1 in white adipose tissue reveals a novel interplay of peroxisome proliferator-activated receptor gamma and sterol regulatory element-binding protein in the regulation of adipogenesis. Kast-Woelbern HR; Dana SL; Cesario RM; Sun L; de Grandpre LY; Brooks ME; Osburn DL; Reifel-Miller A; Klausing K; Leibowitz MD J Biol Chem; 2004 Jun; 279(23):23908-15. PubMed ID: 15073165 [TBL] [Abstract][Full Text] [Related]
12. Very long-chain-fatty acids enhance adipogenesis through coregulation of Elovl3 and PPARγ in 3T3-L1 cells. Kobayashi T; Fujimori K Am J Physiol Endocrinol Metab; 2012 Jun; 302(12):E1461-71. PubMed ID: 22436697 [TBL] [Abstract][Full Text] [Related]
13. PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo. Kershaw EE; Schupp M; Guan HP; Gardner NP; Lazar MA; Flier JS Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1736-45. PubMed ID: 17848638 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms regulating repression of haptoglobin production by peroxisome proliferator-activated receptor-gamma ligands in adipocytes. Vernochet C; Davis KE; Scherer PE; Farmer SR Endocrinology; 2010 Feb; 151(2):586-94. PubMed ID: 19952271 [TBL] [Abstract][Full Text] [Related]
15. Gene expression profile of adipocyte differentiation and its regulation by peroxisome proliferator-activated receptor-gamma agonists. Gerhold DL; Liu F; Jiang G; Li Z; Xu J; Lu M; Sachs JR; Bagchi A; Fridman A; Holder DJ; Doebber TW; Berger J; Elbrecht A; Moller DE; Zhang BB Endocrinology; 2002 Jun; 143(6):2106-18. PubMed ID: 12021175 [TBL] [Abstract][Full Text] [Related]
16. Augmentation of PPARgamma-TAZ interaction contributes to the anti-adipogenic activity of KR62980. Jung H; Lee MS; Jang EJ; Ahn JH; Kang NS; Yoo SE; Bae MA; Hong JH; Hwang ES Biochem Pharmacol; 2009 Nov; 78(10):1323-9. PubMed ID: 19591806 [TBL] [Abstract][Full Text] [Related]
17. Identification of a domain within peroxisome proliferator-activated receptor gamma regulating expression of a group of genes containing fibroblast growth factor 21 that are selectively repressed by SIRT1 in adipocytes. Wang H; Qiang L; Farmer SR Mol Cell Biol; 2008 Jan; 28(1):188-200. PubMed ID: 17954559 [TBL] [Abstract][Full Text] [Related]
18. Selective modulation of promoter recruitment and transcriptional activity of PPARgamma. Sears DD; Hsiao A; Ofrecio JM; Chapman J; He W; Olefsky JM Biochem Biophys Res Commun; 2007 Dec; 364(3):515-21. PubMed ID: 17963725 [TBL] [Abstract][Full Text] [Related]
19. The potential insulin sensitizing and glucose lowering effects of a novel indole derivative in vitro and in vivo. Li YY; Wu HS; Tang L; Feng CR; Yu JH; Li Y; Yang YS; Yang B; He QJ Pharmacol Res; 2007 Oct; 56(4):335-43. PubMed ID: 17889553 [TBL] [Abstract][Full Text] [Related]